| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032873962 |
| P356 | DOI | 10.1186/S13014-015-0340-9 |
| P932 | PMC publication ID | 4341868 |
| P698 | PubMed publication ID | 25889747 |
| P5875 | ResearchGate publication ID | 273504353 |
| P50 | author | Robert C. Miller | Q39182846 |
| Sean S. Park | Q42433723 | ||
| P2093 | author name string | Paul D Brown | |
| Yolanda I Garces | |||
| Kenneth R Olivier | |||
| Kathryn Nelson | |||
| Charles S Mayo | |||
| Dawn Owen | |||
| Daniel J Ma | |||
| Heather Bauer | |||
| P2860 | cites work | Heart irradiation as a risk factor for radiation pneumonitis. | Q33698930 |
| Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates | Q34499545 | ||
| Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review | Q34667302 | ||
| Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours | Q36343856 | ||
| Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience | Q36673518 | ||
| Lung cancer: a model for implementing stereotactic body radiation therapy into practice | Q36887065 | ||
| Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer | Q37420376 | ||
| Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications | Q37675308 | ||
| Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer | Q37884875 | ||
| Use of stereotactic body radiation therapy for medically inoperable multiple primary lung cancer | Q38050193 | ||
| SU-E-T-246: Preliminary Normal Tissue Complication Probability (NTCP) Analysis for Radiation Pneumonitis (RP) after Stereotactic Body Radiotherapy (SBRT). | Q38778662 | ||
| Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study | Q39675331 | ||
| Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial | Q39847699 | ||
| Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis | Q42030396 | ||
| Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. | Q44017103 | ||
| Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy. | Q46014428 | ||
| The North American experience with stereotactic body radiation therapy in non-small cell lung cancer | Q47573835 | ||
| Radiation damage to the heart enhances early radiation-induced lung function loss. | Q47753764 | ||
| Stereotactic body radiation therapy in the treatment of multiple primary lung cancers. | Q50594083 | ||
| Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. | Q51363298 | ||
| Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations. | Q51721308 | ||
| Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. | Q53178520 | ||
| Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions | Q58890327 | ||
| The impact of heart irradiation on dose-volume effects in the rat lung | Q81298464 | ||
| A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy | Q82237274 | ||
| Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy | Q82363173 | ||
| Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study | Q83405180 | ||
| Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution | Q83460904 | ||
| Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors | Q83749144 | ||
| Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung | Q84046719 | ||
| Stereotactic body radiation therapy for lung metastases | Q84501695 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 43 | |
| P577 | publication date | 2015-02-18 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules | |
| P478 | volume | 10 |
| Q51474276 | 23 Lung Metastases Treated by Radiofrequency Ablation Over 10 Years in a Single Patient: Successful Oncological Outcome of a Metastatic Cancer Without Altered Respiratory Function. |
| Q28079625 | A critical review of recent developments in radiotherapy for non-small cell lung cancer |
| Q38679488 | A perspective on the impact of radiation therapy on the immune rheostat |
| Q58779755 | Comparison of clinical efficacy and complications of I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma |
| Q89699660 | Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy |
| Q40997240 | Linear EBUS-guided fiducial marker placement to guide radiotherapy for endobronchial, radiographically occult synchronous primary squamous cell carcinoma of the lung |
| Q50862063 | Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. |
| Q37179624 | Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience |
| Q40172078 | Management of Multifocal Lung Cancer: Results of a Survey |
| Q93378567 | Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers |
| Q38795558 | Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. |
| Q33784339 | Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status |
| Q64111832 | Three discipline collaborative radiation therapy (3 DCRT ) special debate: I would treat all early‐stage NSCLC patients with SBRT |
| Q90376507 | Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison |
| Q92467682 | Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate |
Search more.